Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
about
A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcriptionGenes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphomaNVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent mannerDrug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia.Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML.Accounting for one-channel depletion improves missing value imputation in 2-dye microarray dataImproving missing value imputation of microarray data by using spot quality weights.Identification of proteins involved in neural progenitor cell targeting of gliomas.Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations.Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia.Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth.Comprehensive genomic characterization of five canine lymphoid tumor cell lines.Specific expression of novel long non-coding RNAs in high-hyperdiploid childhood acute lymphoblastic leukemiaThe MLL partial tandem duplication in acute myeloid leukaemia.PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged DiseaseRole of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies.DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemiaPreclinical approaches in chronic myeloid leukemia: from cells to systemsAntigens in chronic myeloid leukemia: implications for vaccine development.A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migrationModeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target.Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations.Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells.Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.LncRNAs downregulated in childhood acute lymphoblastic leukemia modulate apoptosis, cell migration, and DNA damage response.Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.
P2860
Q29958043-E9D53385-1D60-4004-B2F3-52482F2FB901Q38098914-7ABB111B-2EF6-4436-B86A-2F2F7D1D4388Q54604500-ACDD4E2D-4D9A-4360-9FD9-EE2CD27B5BB3Q54813770-324BF8EC-87B3-45C5-88FE-59B7D2ACC1FBQ54814774-1210992A-AE0A-4E9D-9856-A9D4972716B5Q54832265-5FEC3989-DB50-4C3F-8D75-B997FFF15572Q54832338-E74D036F-3E58-4E29-956F-B67D971DA05FQ54898958-49FAA4C7-27D2-4598-92C4-1B318BCD17B7Q54899501-DEBFFCF1-2ED8-4D69-910E-DEDCE808F5FFQ54899833-DCACD8F2-CD88-4CA0-986C-4141C2DFFA61Q54900278-85FAD08E-C3A0-4B68-8B0D-985FCD134D39Q54900299-4A62A1ED-CB0A-4425-BD9F-2E7713FEF355Q54900693-EB7DE726-8A4E-42A9-AFCF-68BBAFF5D1FBQ54901914-297F1098-5D2D-426D-82EC-DC6D5F4FDE5DQ54904898-302FADDC-2381-44F8-8461-BC45282E6C8DQ54905035-230A19B4-8D68-4521-BE64-BD3A37B6DECDQ54905536-9B5C00F8-A320-48DB-A6F9-10BDEEDC5E99Q54905537-CF252B2B-67CD-4E2D-853B-185491CB9788Q54905538-86C7531C-9419-4DDA-BCE3-5810C5E203C9Q54905843-B9ABC1CA-9108-4366-B184-F011ABD30B0FQ54906259-85635321-5963-44F9-A523-168C60F16C90Q54906347-D4CC8E11-D893-42BF-AE22-B00B2F0F5F83Q54906378-F51D44F1-78CC-421E-B212-A7881338C0AAQ54907101-A34AE8EA-3543-43F6-95C2-B5CA03C96D4AQ54907109-3CC293E8-0EAE-438F-BBEF-BCAC11D3EED0Q54907391-ED0DDE2F-3B74-4C02-B073-AF496CB143E4Q54907426-80A14949-DD95-4613-893F-9FB9EA30C904Q54907527-2EF0DB9B-5591-4BC7-BBA6-A1E45F8371F2Q54931741-E167366F-D7E5-4962-B0AD-963E4F168B4BQ54947238-448219BB-8138-4165-85BD-1D38B4896284Q54951304-2F781140-A562-4D9C-9C61-860EDC315AD0Q54952709-F9A2237A-8496-4C19-8025-67A25FB7258DQ54953425-6D6E642A-CEA1-4BFB-84C1-26F1E7466006Q54954758-03D4DCB5-362A-4059-B1DC-E1DAA60C6C2EQ54970859-5312D10F-6B03-4554-8D69-C65187109DA8Q54971725-5957B689-0178-416B-967B-8797D82C826CQ5630035-9F029D7D-F550-43FD-BC7F-23167759F097Q6324626-45C5D074-9E8F-4678-8F7F-91E5635E7CC2Q7670282-C39FA583-4B14-4199-9DDE-8BA79202BC1DQ7863610-4F3F57FC-2E57-495C-BB18-5141FD6C4F62
P1343
Q27645941-FF75998E-C18D-4254-AB97-E97ED4B24218Q28276837-C36DDEE2-C9AE-406B-982C-90BD10259BE1Q28483767-CE927507-0140-4918-953E-80A56D76FCCCQ30409637-93100D59-CD66-484A-A0DC-C755EBD4B28AQ30823304-D097EB18-BF3B-46FB-B10C-66E2394133C9Q31143195-613821E6-03D5-4A0F-8868-1994B9FAF72CQ33247057-8382450E-28F2-44B9-9FDD-C96E5FAAFA27Q33475160-60499453-BBAC-4A9B-B4E0-AA8A2CE3B770Q34244973-1D90EB5F-B028-4CDD-B98F-EEC87AE54D31Q34503575-F47FE668-9D80-4E7F-ADEB-0AC32A8C9C0EQ35990849-B15B51D8-4EB1-4064-9857-73B5EC8E4805Q36136307-F718534E-A69A-4703-9BE3-B31667057970Q36323903-D2A4FF70-BB72-4F4F-8F50-1E3886D30EB3Q36590734-88E98789-9591-4018-8AEC-8F62F5E40248Q36735211-9FE7F77F-662B-42FC-BA21-24E5D26AA2BEQ37097042-21165400-F7C9-49D0-9868-C6483ECFEBA9Q37188783-54DDD91D-C035-4893-9448-F9E68B8F7B07Q37676954-4D5FDFDC-D251-4BD5-9088-EA7ADEC3377DQ37950233-215A4ACE-18DB-4738-90E1-57B688C64513Q38726016-B3644059-5A00-48F2-9553-3B0C9C268C96Q39249858-F84886B9-CD7E-473C-9655-BA6A5636B36AQ39809596-4FEFC897-AC54-48F5-9BBE-DE4AEA8886BEQ40276097-46575514-4B1B-4D30-BE0D-D950A908D0E0Q41072362-8F590F5A-0488-4129-A658-8765DDFE4776Q41634601-8D210A0C-93E4-497D-A4AC-22AD82B012E2Q43248878-122B8B2D-0EA2-4579-9266-79E46C2742C1Q47235517-A299413A-FDDB-4C03-9303-19D83B5BD3C2Q50775513-7FD14CC5-B460-4195-8FCD-248394B00DDC
P2860
Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Gene expression profiling of l ...... specific genetic aberrations.
@en
type
label
Gene expression profiling of l ...... specific genetic aberrations.
@en
prefLabel
Gene expression profiling of l ...... specific genetic aberrations.
@en
P2093
P2860
P4510
P50
P356
P1433
P1476
Gene expression profiling of l ...... h specific genetic aberrations
@en
P2093
Johansson B
Lindgren D
Mitelman F
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403749
P577
2005-06-01T00:00:00Z
P5875
P6179
1007163297